Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99

By Liu J-Q.  

International Immunology, Vol. 10, Iss. 8, 1998-08 ,pp. : 1139-1148

Oxford University Press

Access to resources Recommend Favorite

Combined Nasal Administration of Encephalitogenic Myelin Basic Protein Peptide 68–86 and IL-10 Suppressed Incipient Experimental Allergic Encephalomyelitis in Lewis Rats

By Xu L-Y.   Yang J-S.   Huang Y-M.   Levi M.   Link H.   Xiao B-G.  

Clinical Immunology, Vol. 96, Iss. 3, 2000-09 ,pp. : 205-211

Academic Press

Access to resources Recommend Favorite

Beneficial effect of orally administered myelin basic protein inEAE-susceptible Lewis rats in a model of acute CNSdegeneration

By Monsonego A.   Beserman Z.P.   Kipnis J.   Yoles E.   Weiner H.L.   Schwartz M.  

Journal of Autoimmunity, Vol. 21, Iss. 2, 2003-09 ,pp. : 131-138

Elsevier

Access to resources Recommend Favorite

2-buten-4-olide (2-B4O) Inhibits Experimental Allergic Encephalomyelitis (EAE) in Lewis Rats

By Naiki M.   Takeoka Y.   Yago H.   Kurimoto Y.   Gershwin E.M.   Suehiro S.  

Journal of Autoimmunity, Vol. 8, Iss. 5, 1995-10 ,pp. : 727-739

Academic Press

Access to resources Recommend Favorite

Intratracheal Administration to the Lung Enhances Therapeutic Benefit of an MBP Peptide in the Treatment of Murine Experimental Autoimmune Encephalomyelitis

By Pietropaolo M.   Olson C.D.   Reiseter B.S.   Kasaian M.T.   Happ M.P.  

Clinical Immunology, Vol. 95, Iss. 2, 2000-05 ,pp. : 104-116

Academic Press

Access to resources Recommend Favorite